NCT01536652View on ClinicalTrials.gov

Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes

CompletedOBSERVATIONAL

Enrollment

4,994

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart 30

Prescription at the discretion of the treating physician

Trial Locations (1)

55127

Mainz

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY